Clinical Trials Directory

Trials / Unknown

UnknownNCT03748407

Determination of Baseline Thyroid Status Values in French Adult Population

Determination of Baseline Thyroid Status Values

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
600 (estimated)
Sponsor
University Hospital, Caen · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

The objective of this study is to establish reference values in the general population from a Beckman Coulter DxI chemiluminescence assay. Indeed, the lack of harmonization of the methods of the dosage remains a major difficulty to optimize the management of patients with thyroid disease. This supplier has recently optimized its dosing kit according to the 3rd international standard of the WHO (IRB 81/565) for the TSH (Thyroid Stimulating Hormon). It is necessary to carry out a study of the distribution of the values of this TSH within our metropolitan population. The current data proposed by the supplier come from a study of a North American population. investigators propose to define usual values for thyroid status markers (TSH, FT4 \[free thyroxine\], FT3 \[free triiodothyroxine\]) from healthy EFS (French Blood Establishment) donors who meet the standard exclusion criteria for this type of study.

Conditions

Interventions

TypeNameDescription
OTHERDosages of Thyroid parametersDosages of the following parameters: TSH, FT4 FT3, TGAb (Tyroglobulin antibody) , TPO Ab (ThyroPeroxydase Antibody)

Timeline

Start date
2018-11-30
Primary completion
2018-12-01
Completion
2019-01-31
First posted
2018-11-20
Last updated
2018-11-20

Source: ClinicalTrials.gov record NCT03748407. Inclusion in this directory is not an endorsement.